BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17895425)

  • 21. High-Level Macrolide-Resistant Moraxella catarrhalis and Development of an Allele-Specific PCR Assay for Detection of 23S rRNA Gene A2330T Mutation: A Three-Year Study at a Chinese Tertiary Hospital.
    Liu Y; Xu H; Xu Z; Kudinha T; Fan X; Xiao M; Kong F; Sun H; Xu Y
    Microb Drug Resist; 2015 Oct; 21(5):507-11. PubMed ID: 25923017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global and local variations in antimicrobial susceptibilities and resistance development in the major respiratory pathogens.
    Alpuche C; Garau J; Lim V
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S135-8. PubMed ID: 17945468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRELP Enhances Host Innate Immunity against the Respiratory Tract Pathogen
    Liu G; Ermert D; Johansson ME; Singh B; Su YC; Paulsson M; Riesbeck K; Blom AM
    J Immunol; 2017 Mar; 198(6):2330-2340. PubMed ID: 28148731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of clinical isolates of Moraxella catarrhalis by randomly amplified polymorphic DNA fingerprinting.
    Theoga Raj CJ; Shankar EM; Rothan HA; Rao UA
    J Mol Microbiol Biotechnol; 2014; 24(4):270-8. PubMed ID: 25277715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of a pediatric clinical isolate of Moraxella catarrhalis with resistance to macrolides and quinolones.
    Iwata S; Sato Y; Toyonaga Y; Hanaki H; Sunakawa K
    J Infect Chemother; 2015 Apr; 21(4):308-11. PubMed ID: 25481761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine targets against Moraxella catarrhalis.
    Ren D; Pichichero ME
    Expert Opin Ther Targets; 2016; 20(1):19-33. PubMed ID: 26565427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related genotypic and phenotypic differences in Moraxella catarrhalis isolates from children and adults presenting with respiratory disease in 2001-2002.
    Verhaegh SJC; Streefland A; Dewnarain JK; Farrell DJ; van Belkum A; Hays JP
    Microbiology (Reading); 2008 Apr; 154(Pt 4):1178-1184. PubMed ID: 18375810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms.
    Hays JP; van Selm S; Hoogenboezem T; Estevão S; Eadie K; van Veelen P; Tommassen J; van Belkum A; Hermans PW
    J Bacteriol; 2005 Dec; 187(23):7977-84. PubMed ID: 16291671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome sequence of Moraxella catarrhalis RH4, an isolate of seroresistant lineage.
    Zomer A; de Vries SP; Riesbeck K; Meinke AL; Hermans PW; Bootsma HJ
    J Bacteriol; 2012 Dec; 194(24):6969. PubMed ID: 23209224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in antibiotic resistance among respiratory tract pathogens in children in two regions near France, a high level resistance country.
    Zbinden R
    Eur J Pediatr; 2006 Jan; 165(1):1-2. PubMed ID: 16133243
    [No Abstract]   [Full Text] [Related]  

  • 31. Moraxella catarrhalis coaggregates with Streptococcus pyogenes and modulates interactions of S. pyogenes with human epithelial cells.
    Lafontaine ER; Wall D; Vanlerberg SL; Donabedian H; Sledjeski DD
    Infect Immun; 2004 Nov; 72(11):6689-93. PubMed ID: 15501804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence.
    Murphy TF; Brauer AL; Johnson A; Kirkham C
    PLoS One; 2016; 11(7):e0158689. PubMed ID: 27391026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular pathogenesis of infections caused by Moraxella catarrhalis in children.
    Bernhard S; Spaniol V; Aebi C
    Swiss Med Wkly; 2012; 142():w13694. PubMed ID: 23136074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and laboratory aspects of Moraxella catarrhalis bacteremia in children.
    Ahmed A; Broides A; Givon-Lavi N; Peled N; Dagan R; Greenberg D
    Pediatr Infect Dis J; 2008 May; 27(5):459-61. PubMed ID: 18360302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrolide and tetracycline resistance among Moraxella catarrhalis isolates from 2009 to 2011.
    Flamm RK; Sader HS; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2012 Oct; 74(2):198-200. PubMed ID: 22819241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic resistance patterns among respiratory pathogens at a German university children's hospital over a period of 10 years.
    Arri SJ; Fluegge K; Mueller U; Berner R
    Eur J Pediatr; 2006 Jan; 165(1):9-13. PubMed ID: 16133241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis.
    Saito R; Nonaka S; Fujinami Y; Matsuoka S; Nakajima S; Nishiyama H; Okamura N
    J Infect Chemother; 2014 Jan; 20(1):6-8. PubMed ID: 24462416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune evasion of Moraxella catarrhalis involves ubiquitous surface protein A-dependent C3d binding.
    Hallström T; Nordström T; Tan TT; Manolov T; Lambris JD; Isenman DE; Zipfel PF; Blom AM; Riesbeck K
    J Immunol; 2011 Mar; 186(5):3120-9. PubMed ID: 21270401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The respiratory pathogen moraxella catarrhalis binds to laminin via ubiquitous surface proteins A1 and A2.
    Tan TT; Forsgren A; Riesbeck K
    J Infect Dis; 2006 Aug; 194(4):493-7. PubMed ID: 16845633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Branhamella catarrhalis as a disease pathogen].
    Simon C
    Fortschr Med; 1991 Jul; 109(22):447-8. PubMed ID: 1937324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.